UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER Trademark
Trademark Overview
On Monday, January 30, 2023, a trademark application was filed for UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER with the United States Patent and Trademark Office. The USPTO has given the UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER trademark a serial number of 97772311. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 14, 2024. This trademark is owned by Siren Biotechnology, Inc.. The UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
General Information
| Serial Number | 97772311 |
| Word Mark | UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER |
| Filing Date | Monday, January 30, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, February 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer |
| Goods and Services | Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 16, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 16, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Siren Biotechnology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94158 |
Trademark Events
| Event Date | Event Description |
| Wednesday, February 14, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, February 14, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, October 31, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 31, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 31, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, October 27, 2023 | ASSIGNED TO EXAMINER |
| Thursday, February 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 2, 2023 | NEW APPLICATION ENTERED |
